Beyond A1C: exploring continuous glucose monitoring metrics in managing diabetes
Open accessThe DOI matches its Crossref record; 129 of the 175 references it cites were found in a registry or an index.
Abstract
Hemoglobin A1c (HbA1c) has long been considered a cornerstone of diabetes mellitus (DM) management, as both an indicator of average glycemia and a predictor of long-term complications among people with DM. However, HbA1c is subject to non-glycemic influences which confound interpretation and as a measure of average glycemia does not provide information regarding glucose trends or about the occurrence of hypoglycemia and/or hyperglycemia episodes. As such, solitary use of HbA1c, without accompanying glucose data, does not confer actionable information that can be harnessed to guide targeted therapy in many patients with DM. While conventional capillary blood glucose monitoring (BGM) sheds light on momentary glucose levels, in practical use the inherent infrequency of measurement precludes elucidation of glycemic trends or reliable detection of hypoglycemia or hyperglycemia episodes. In contrast, continuous glucose monitoring (CGM) data reveal glucose trends and potentially undetected hypo- and hyperglycemia patterns that can occur between discrete BGM measurements. The use of CGM has grown significantly over the past decades as an ever-expanding body of literature demonstrates a multitude of clinical benefits for people with DM. Continually improving CGM accuracy and ease of use have further fueled the widespread adoption of CGM. Furthermore, percent time in range correlates well with HbA1c, is accepted as a validated indicator of glycemia, and is associated with the risk of several DM complications. We explore the benefits and limitations of CGM use, the use of CGM in clinical practice, and the application of CGM to advanced diabetes technologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The primary outcome was met and showed benefit in adults of all ages (38,53,54), including seniors (55-57).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
Self-citationAssociation of Health Literacy With Diabetes Outcomes
Schillinger, D. (2002) · JAMA · doi:10.1001/jama.288.4.475 · Cited by 1,938
Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Brown, S. A., Kovatchev, B. P., Raghinaru, D., Lum, J. W., Buckingham, B. A., Kudva, Y. C., Laffel, L. M., Levy, C. J., Pinsker, J. E., Wadwa, R. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1907863 · Cited by 1,030
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Feig, D. S., Donovan, L. E., Corcoy, R., Murphy, K. E., Amiel, S. A., Hunt, K. F., Asztalos, E., Barrett, J. F. R., Sanchez, J. J., de Leiva, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32400-5 · Cited by 803
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
Beck, R. W., Bergenstal, R. M., Riddlesworth, T. D., Kollman, C., Li, Z., Brown, A. S., & Close, K. L. (2019) · Diabetes Care · doi:10.2337/dc18-1444 · Cited by 793
Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities
Rodbard, D. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0417 · Cited by 737
Lind, M., Polonsky, W., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Schwarz, E., Ólafsdóttir, A. F., Frid, A., Wedel, H., et al. (2017) · JAMA · doi:10.1001/jama.2016.19976 · Cited by 705
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
(1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-46-2-356 · Cited by 696
The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes
King, P., Peacock, I., & Donnelly, R. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00092.x · Cited by 695
Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring
Bergenstal, R. M., Beck, R. W., Close, K. L., Grunberger, G., Sacks, D. B., Kowalski, A., Brown, A. S., Heinemann, L., Aleppo, G., Ryan, D. B., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1581 · Cited by 684
Self-citation6. Glycemic Targets: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s006 · Cited by 684
Self-citationBeck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2855 · Cited by 635
Haak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-016-0223-6 · Cited by 623
The New England Journal of Medicine
(1928) · New England Journal of Medicine · doi:10.1056/nejm192802231980115 · Cited by 603
Garg, S. K., Weinzimer, S. A., Tamborlane, W. V., Buckingham, B. A., Bode, B. W., Bailey, T. S., Brazg, R. L., Ilany, J., Slover, R. H., Anderson, S. M., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0421 · Cited by 585
Martens, T., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., Pop-Busui, R., Philis-Tsimikas, A., Bao, S., Umpierrez, G., et al. (2021) · JAMA · doi:10.1001/jama.2021.7444 · Cited by 543
Self-citationDeiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
Heinemann, L., Freckmann, G., Ehrmann, D., Faber-Heinemann, G., Guerra, S., Waldenmaier, D., & Hermanns, N. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30297-6 · Cited by 522
Diabetes/Metabolism Research and Reviews
(2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/(issn)1520-7560 · Cited by 511
the SWITCH Study Group, Battelino, T., Conget, I., Olsen, B., Schütz-Fuhrmann, I., Hommel, E., Hoogma, R., Schierloh, U., Sulli, N., & Bolinder, J. (2012) · Diabetologia · doi:10.1007/s00125-012-2708-9 · Cited by 494
Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes
Battelino, T., Phillip, M., Bratina, N., Nimri, R., Oskarsson, P., & Bolinder, J. (2011) · Diabetes Care · doi:10.2337/dc10-1989 · Cited by 490
The relationships between time in range, hyperglycemia metrics, and HbA1c
Beck, R. W., Bergenstal, R. M., Cheng, P., Kollman, C., Carlson, A. L., Johnson, M. L., & Rodbard, D. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818822496 · Cited by 479
Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c
Cohen, R. M., Franco, R. S., Khera, P. K., Smith, E. P., Lindsell, C. J., Ciraolo, P. J., Palascak, M. B., & Joiner, C. H. (2008) · Blood · doi:10.1182/blood-2008-04-154112 · Cited by 478
The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading
Beck, R. W., Connor, C. G., Mullen, D. M., Wesley, D. M., & Bergenstal, R. M. (2017) · Diabetes Care · doi:10.2337/dc17-0636 · Cited by 477
The relationship of hemoglobin A1C to time-in-range in patients with diabetes
Vigersky, R. A., & McMahon, C. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0310 · Cited by 464
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor
Garg, S., Zisser, H., Schwartz, S., Bailey, T., Kaplan, R., Ellis, S., & Jovanovic, L. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1686 · Cited by 433
The effect of continuous glucose monitoring in well-controlled type 1 diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0108 · Cited by 399
Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes
Monnier, L., Colette, C., Wojtusciszyn, A., Dejager, S., Renard, E., Molinari, N., & Owens, D. R. (2017) · Diabetes Care · doi:10.2337/dc16-1769 · Cited by 390
van Beers, C. A. J., DeVries, J. H., Kleijer, S. J., Smits, M. M., Geelhoed-Duijvestijn, P. H., Kramer, M. H. H., Diamant, M., Snoek, F. J., & Serné, E. H. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30193-0 · Cited by 386
Pratley, R. E., Kanapka, L. G., Rickels, M. R., Ahmann, A., Aleppo, G., Beck, R., Bhargava, A., Bode, B. W., Carlson, A., Chaytor, N. S., et al. (2020) · JAMA · doi:10.1001/jama.2020.6928 · Cited by 375
Self-citationReal-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
Wong, J. C., Foster, N. C., Maahs, D. M., Raghinaru, D., Bergenstal, R. M., Ahmann, A. J., Peters, A. L., Bode, B. W., Aleppo, G., Hirsch, I. B., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0303 · Cited by 318
Self-citationReview of hemoglobin A1c in the management of diabetes
GALLAGHER, E. J., LE ROITH, D., & BLOOMGARDEN, Z. (2009) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00009.x · Cited by 304
Brown, S. A., Forlenza, G. P., Bode, B. W., Pinsker, J. E., Levy, C. J., Criego, A. B., Hansen, D. W., Hirsch, I. B., Carlson, A. L., Bergenstal, R. M., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0172 · Cited by 286
Self-citationLu, J., Wang, C., Shen, Y., Chen, L., Zhang, L., Cai, J., Lu, W., Zhu, W., Hu, G., Xia, T., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1862 · Cited by 282
Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control
Riddlesworth, T. D., Beck, R. W., Gal, R. L., Connor, C. G., Bergenstal, R. M., Lee, S., & Willi, S. M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0455 · Cited by 266
Physiological Differences Between Interstitial Glucose and Blood Glucose Measured in Human Subjects
Kulcu, E., Tamada, J. A., Reach, G., Potts, R. O., & Lesho, M. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2405 · Cited by 251
Forlenza, G. P., Li, Z., Buckingham, B. A., Pinsker, J. E., Cengiz, E., Wadwa, R. P., Ekhlaspour, L., Church, M. M., Weinzimer, S. A., Jost, E., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0771 · Cited by 246
Yoo, H. J., An, H. G., Park, S. Y., Ryu, O. H., Kim, H. Y., Seo, J. A., Hong, E. G., Shin, D. H., Kim, Y. H., Kim, S. G., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.06.015 · Cited by 244
A View Beyond HbA1c: Role of Continuous Glucose Monitoring
Chehregosha, H., Khamseh, M. E., Malek, M., Hosseinpanah, F., & Ismail-Beigi, F. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0619-1 · Cited by 235
Ruedy, K. J., Parkin, C. G., Riddlesworth, T. D., & Graham, C. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817704445 · Cited by 225
Multicenter, randomized trial of a bionic pancreas in type 1 diabetes
Bionic Pancreas Research Group (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2205225 · Cited by 216
O’Connell, M. A., Donath, S., O’Neal, D. N., Colman, P. G., Ambler, G. R., Jones, T. W., Davis, E. A., & Cameron, F. J. (2009) · Diabetologia · doi:10.1007/s00125-009-1365-0 · Cited by 211
(1994) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(94)92210-1 · Cited by 207
Racial-Ethnic Inequity in Young Adults With Type 1 Diabetes
Agarwal, S., Kanapka, L. G., Raymond, J. K., Walker, A., Gerard-Gonzalez, A., Kruger, D., Redondo, M. J., Rickels, M. R., Shah, V. N., Butler, A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa236 · Cited by 205
British Journal of Clinical Pharmacology
(2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04428.x · Cited by 200
Ehrhardt, N. M., Chellappa, M., Walker, M. S., Fonda, S. J., & Vigersky, R. A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500320 · Cited by 199
A history of continuous glucose monitors (CGMs) in self-monitoring of diabetes mellitus
Olczuk, D., & Priefer, R. (2018) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2017.09.005 · Cited by 194
Pickup, J. C., Ford Holloway, M., & Samsi, K. (2015) · Diabetes Care · doi:10.2337/dc14-1855 · Cited by 189
Deshmukh, H., Wilmot, E. G., Gregory, R., Barnes, D., Narendran, P., Saunders, S., Furlong, N., Kamaruddin, S., Banatwalla, R., Herring, R., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0738 · Cited by 175
Intermittently scanned continuous glucose monitoring for type 1 diabetes
Leelarathna, L., Evans, M. L., Neupane, S., Rayman, G., Lumley, S., Cranston, I., Narendran, P., Barnard-Kelly, K., Sutton, C. J., Elliott, R. A., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2205650 · Cited by 174
Roussel, R., Riveline, J.-P., Vicaut, E., de Pouvourville, G., Detournay, B., Emery, C., Levrat-Guillen, F., & Guerci, B. (2021) · Diabetes Care · doi:10.2337/dc20-1690 · Cited by 173
Heinemann, L., Schoemaker, M., Schmelzeisen-Redecker, G., Hinzmann, R., Kassab, A., Freckmann, G., Reiterer, F., & Del Re, L. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819855670 · Cited by 170
Bergenstal, R. M., Ahmann, A. J., Bailey, T., Beck, R. W., Bissen, J., Buckingham, B., Deeb, L., Dolin, R. H., Garg, S. K., Goland, R., et al. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700234 · Cited by 166
Mayeda, L., Katz, R., Ahmad, I., Bansal, N., Batacchi, Z., Hirsch, I. B., Robinson, N., Trence, D. L., Zelnick, L., & de Boer, I. H. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000991 · Cited by 162
“Turn it Off!”: Diabetes Device Alarm Fatigue Considerations for the Present and the Future
Shivers, J. P., Mackowiak, L., Anhalt, H., & Zisser, H. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700324 · Cited by 158
Prevention of Hypoglycemia by Using Low Glucose Suspend Function in Sensor-Augmented Pump Therapy
Danne, T., Kordonouri, O., Holder, M., Haberland, H., Golembowski, S., Remus, K., Bläsig, S., Wadien, T., Zierow, S., Hartmann, R., et al. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0084 · Cited by 151
Hásková, A., Radovnická, L., Petruželková, L., Parkin, C. G., Grunberger, G., Horová, E., Navrátilová, V., Kádě, O., Matoulek, M., Prázný, M., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0112 · Cited by 146
Ambulatory Glucose Profile: Representation of Verified Self-Monitored Blood Glucose Data
Mazze, R. S., Lucido, D., Langer, O., Hartmann, K., & Rodbard, D. (1987) · Diabetes Care · doi:10.2337/diacare.10.1.111 · Cited by 144
Haidar, A., Tsoukas, M. A., Bernier-Twardy, S., Yale, J.-F., Rutkowski, J., Bossy, A., Pytka, E., El Fathi, A., Strauss, N., & Legault, L. (2020) · Diabetes Care · doi:10.2337/dc19-1922 · Cited by 138
Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology
Galindo, R. J., & Aleppo, G. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108502 · Cited by 133
Self-citationOptimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring
Xing, D., Kollman, C., Beck, R. W., Tamborlane, W. V., Laffel, L., Buckingham, B. A., Wilson, D. M., Weinzimer, S., Fiallo-Scharer, R., & Ruedy for the Juvenile Diabetes Research Foundation Continuo, K. J. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0156 · Cited by 131
Hypoglycemia in Type 2 Diabetes - More Common Than You Think: A Continuous Glucose Monitoring Study
Gehlaut, R. R., Dogbey, G. Y., Schwartz, F. L., Marling, C. R., & Shubrook, J. H. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815581052 · Cited by 131
Osborn, C. Y., Cavanaugh, K., Wallston, K. A., White, R. O., & Rothman, R. L. (2009) · Diabetes Care · doi:10.2337/dc09-0425 · Cited by 127
Sherr, J. L., Heinemann, L., Fleming, G. A., Bergenstal, R. M., Bruttomesso, D., Hanaire, H., Holl, R. W., Petrie, J. R., Peters, A. L., & Evans, M. (2023) · Diabetologia · doi:10.1007/s00125-022-05744-z · Cited by 123
Saydah, S., Cowie, C. C., Eberhardt, M. S., de Rekeneire, N., & Narayan, K. M. V. (2007) · PubMed · Cited by 122
Pettus, J., & Edelman, S. V. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816663747 · Cited by 121
Diabetes Research and Clinical Practice
(2013) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(13)70001-9 · Cited by 120
Wright, E. E., Kerr, M. S. D., Reyes, I. J., Nabutovsky, Y., & Miller, E. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0069 · Cited by 115
Odugbesan, O., Addala, A., Nelson, G., Hopkins, R., Cossen, K., Schmitt, J., Indyk, J., Jones, N.-H. Y., Agarwal, S., Rompicherla, S., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0042 · Cited by 113
The application of simple metrics in the assessment of glycaemic variability
Monnier, L., Colette, C., & Owens, D. R. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.02.008 · Cited by 106
Kowaltowski, A. J., & Abdulkader, F. (2020) · Springer eBooks · doi:10.1007/978-3-030-50968-2_9 · Cited by 106
Effect of Acetaminophen on CGM Glucose in an Outpatient Setting
Maahs, D. M., DeSalvo, D., Pyle, L., Ly, T., Messer, L., Clinton, P., Westfall, E., Wadwa, R. P., & Buckingham, B. (2015) · Diabetes Care · doi:10.2337/dc15-1096 · Cited by 102
Tumminia, A., Crimi, S., Sciacca, L., Buscema, M., Frittitta, L., Squatrito, S., Vigneri, R., & Tomaselli, L. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2557 · Cited by 100
Yoo, J. H., Choi, M. S., Ahn, J., Park, S. W., Kim, Y., Hur, K. Y., Jin, S.-M., Kim, G., & Kim, J. H. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0499 · Cited by 98
Susceptibility of Interstitial Continuous Glucose Monitor Performance to Sleeping Position
Mensh, B. D., Wisniewski, N. A., Neil, B. M., & Burnett, D. R. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700408 · Cited by 97
Benefits and Challenges of Diabetes Technology Use in Older Adults
Toschi, E., & Munshi, M. N. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.001 · Cited by 91
The Hybrid Closed-Loop System: Evolution and Practical Applications
Weaver, K. W., & Hirsch, I. B. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0091 · Cited by 84
Bao, S., Bailey, R., Calhoun, P., & Beck, R. W. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0494 · Cited by 81
New, J. P., Ajjan, R., Pfeiffer, A. F. H., & Freckmann, G. (2015) · Diabetic Medicine · doi:10.1111/dme.12713 · Cited by 80
Skin and Adhesive Issues With Continuous Glucose Monitors: A Sticky Situation
Englert, K., Ruedy, K., Coffey, J., Caswell, K., Steffen, A., Levandoski, L., for the Diabetes Research in Children (DirecNet) Study Group, Tsalikian, E., Tansey, M. J., Coffey, J., et al. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814529893 · Cited by 77
Hemoglobinopathies and Hemoglobin A1c in Diabetes Mellitus
Klonoff, D. C. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819841698 · Cited by 77
Miller, K. M., Kanapka, L. G., Rickels, M. R., Ahmann, A. J., Aleppo, G., Ang, L., Bhargava, A., Bode, B. W., Carlson, A., Chaytor, N. S., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0503 · Cited by 73
Self-citationRanjan, A. G., Rosenlund, S. V., Hansen, T. W., Rossing, P., Andersen, S., & Nørgaard, K. (2020) · Diabetes Care · doi:10.2337/dc20-0909 · Cited by 72
McNally, P. G., Dean, J. D., Morris, A. D., Wilkinson, P. D., Compion, G., & Heller, S. R. (2007) · Diabetes Care · doi:10.2337/dc06-1328 · Cited by 71
Laffel, L. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0380 · Cited by 70
Infante, M., Baidal, D. A., Rickels, M. R., Fabbri, A., Skyler, J. S., Alejandro, R., & Ricordi, C. (2021) · Artificial Organs · doi:10.1111/aor.14023 · Cited by 66
Riddlesworth, T., Price, D., Cohen, N., & Beck, R. W. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0281-4 · Cited by 65
Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes
Steineck, I. I. K., Ranjan, A. G., Nørgaard, K., & Schmidt, S. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816672689 · Cited by 63
Associations between HbA1c and continuous glucose monitoring‐derived glycaemic variables
Hirsch, I. B., Welsh, J. B., Calhoun, P., Puhr, S., Walker, T. C., & Price, D. A. (2019) · Diabetic Medicine · doi:10.1111/dme.14065 · Cited by 62
Nathanson, D., Svensson, A.-M., Miftaraj, M., Franzén, S., Bolinder, J., & Eeg-Olofsson, K. (2021) · Diabetologia · doi:10.1007/s00125-021-05437-z · Cited by 61
Weber, K., Lohmann, T., Busch, K., Donati-Hirsch, I., & Riel, R. (2007) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-984452 · Cited by 59
Szmuilowicz, E. D., Levy, C. J., Buschur, E. O., & Polsky, S. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0540 · Cited by 58
Self-citationIntroduction: History of Glucose Monitoring
Hirsch, I. B. (2018) · ADA Clinical Compendia · doi:10.2337/db20181-1 · Cited by 57
(2013) · Current Diabetes Reports · doi:10.1007/11892.1539-0829 · Cited by 56
Psychosocial Aspects of Continuous Glucose Monitoring: Connecting to the Patients’ Experience
Kubiak, T., Mann, C. G., Barnard, K. C., & Heinemann, L. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816651450 · Cited by 49
Elliott, T., Beca, S., Beharry, R., Tsoukas, M. A., Zarruk, A., & Abitbol, A. (2021) · Diabetes and Vascular Disease Research · doi:10.1177/14791641211021374 · Cited by 49
Emerging Technologies for Diabetes Care
Bailey, T. S., Walsh, J., & Stone, J. Y. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0115 · Cited by 47
Espinoza, J., Xu, N. Y., Nguyen, K. T., & Klonoff, D. C. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211058148 · Cited by 46
Wakasugi, S., Mita, T., Katakami, N., Okada, Y., Yoshii, H., Osonoi, T., Nishida, K., Shiraiwa, T., Torimoto, K., Kurozumi, A., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001923 · Cited by 45
Pop‐Busui, R., Umpierrez, G. E., BIGGS, W. C., Orozco, I. J., Nguyen, Q. T., Philis‐Tsimikas, A., Bergenstal, R. M., Price, D. A., Buse, J. B., Ruedy, K. J., et al. (2024) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/v4zy-1y17 · Cited by 44
Self-citationPsychosocial aspects of diabetes technology
Kubiak, T., Priesterroth, L., & Barnard-Kelly, K. D. (2020) · Diabetic Medicine · doi:10.1111/dme.14234 · Cited by 44
Herrero, P., Alalitei, A., Reddy, M., Georgiou, P., & Oliver, N. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0387 · Cited by 43
Oser, T. K., Litchman, M. L., Allen, N. A., Kwan, B. M., Fisher, L., Jortberg, B. T., Polonsky, W. H., & Oser, S. M. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01408-1 · Cited by 43
Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes
Kravarusic, J., & Aleppo, G. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.006 · Cited by 42
Self-citationDiscordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without Diabetes
Shah, V. N., Vigers, T., Pyle, L. L., Calhoun, P. M., & Bergenstal, R. M. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0544 · Cited by 41
Diabetes Research and Clinical Practice
Chraïbi, A. (2021) · Journal of Diabetic Complications & Medicine · doi:10.37421/2475-3211.2021.6.e10 · Cited by 40
Hermanns, N., Schumann, B., Kulzer, B., & Haak, T. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814524105 · Cited by 39
Endocrinology and Metabolism Clinics of North America
(2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(20)30051-7 · Cited by 32
Kruger, D. F., & Anderson, J. E. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0193 · Cited by 30
Szmuilowicz, E. D., & Aleppo, G. (2022) · Postgraduate Medicine · doi:10.1080/00325481.2022.2110507 · Cited by 27
Isaacson, B., Kaufusi, S., Sorensen, J., Joy, E. A., Jones, C., Ingram, V., Mark, N., Phillips, M., & Briesacher, M. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820955228 · Cited by 26
Impact of Different Types of Data Loss on Optimal Continuous Glucose Monitoring Sampling Duration
Aktürk, H. K., Herrero, P., Oliver, N. S., Wise, H., Eikermann, E., Snell‐Bergeon, J. K., & Shah, V. N. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0093 · Cited by 25
Inequity in Adoption of Advanced Diabetes Technologies Among Medicare Fee-for-service Beneficiaries
Wherry, K., Zhu, C., & Vigersky, R. A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab869 · Cited by 24
Li, J., Li, Y., Ma, W., Liu, Y., Yin, X., Xie, C., Bai, J., & Zhang, M. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.09.028 · Cited by 23
Interferent effect of hydroxyurea on continuous glucose monitoring
Szmuilowicz, E. D., & Aleppo, G. (2021) · Diabetes Care · doi:10.2337/dc20-3114 · Cited by 23
Self-citationContinuous glucose monitoring in primary care – are we there?
Martens, T. W. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000689 · Cited by 21
(2013) · Current Cardiology Reports · doi:10.1007/11886.1534-3170 · Cited by 21
Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes
Zhou, K., & Isaacs, D. M. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01733-1 · Cited by 20
Mayo, C. W., Fishbein, M., Covet, S. S., Armstrong, H. G., & Warren, S. (1953) · Postgraduate Medicine · doi:10.1080/00325481.1953.11711400 · Cited by 19
The Evidence Base for Continuous Glucose Monitoring
Peters, A. L. (2018) · ADA Clinical Compendia · doi:10.2337/db20181-3 · Cited by 11
Selvin, E., Wang, D., Rooney, M. R., Echouffo-Tcheugui, J. B., Fang, M., Zeger, S. L., Sartini, J., Tang, O., Coresh, J., Aurora, R. N., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0178 · Cited by 9
Diabetes and Metabolic Syndrome
Wilbanks, S. (2012) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2012.09.013 · Cited by 6
Diabetes Numeracy: An overlooked factor in understanding racial disparities in glycemic control
Osborn, C. Y., Cavanaugh, K., Wallston, K. A., White, R. E., & Rothman, R. L. (2009) · doi:10.13016/sxsv-daoq · Cited by 6
Cited by
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
Self-citation7. Diabetes Technology: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s007 · Cited by 280
Self-citationLu, J., Ying, Z., Wang, P., Fu, M., Han, C., & Zhang, M. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15328 · Cited by 39
“26 Several studies 27 – 31 have shown a significant correlation between TIR and diabetic microvascular complications, cardiovascular mortality and all-cause mortality.”
BackgroundRosenfeld, R. M., Grega, M. L., Karlsen, M. C., Dabrh, A. M. A., Aurora, R. N., Bonnet, J. P., Donnell, L., Fitzpatrick, S. L., Frates, E. P., Joy, E. A., et al. (2025) · American Journal of Lifestyle Medicine · doi:10.1177/15598276251325488 · Cited by 54
Aktürk, H. K., Battelino, T., Castañeda, J., Arrieta, A., van den Heuvel, T. R. A., & Cohen, O. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0432 · Cited by 27
“18,19 22 Standardized CGM metrics have been established by the International Consensus.”
Metadata
- Authors
- Friedman, J. G., Coyne, K., Aleppo, G., & Szmuilowicz, E. D.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Szmuilowicz, Emily D
- Venue
- Endocrine Connections
- Publisher
- Bioscientifica
- Published
- 2023-04-18
- Volume
- 12
- Issue
- 7
- ISSN
- 2049-3614 (ISSN-L)
- PMC
- PMC10305570
- OpenAlex
- W4366239178
- Cited by
- 22
- References
- 175
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 7 · 2023: 1
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Endocrine Connections (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- continuous glucose monitoring, diabetes management, HbA1c limitations, glycemic variability, hypoglycemia detection, capillary blood glucose monitoring, diabetes complications, diabetes technology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

